1. Summary Information
|
Country |
India |
||
|
Company Name |
AKUMS DRUGS AND
PHARMACEUTICALS LIMITED |
Principal Name 1 |
Mr. Sanjeev Jain |
|
Status |
Good |
Principal Name 2 |
Mr. Sandeep Jain |
|
Registration # |
55-125888 |
||
|
Street Address |
304, Mohan Place, LSC, Saraswati Vihar, New Delhi-110 034, India |
||
|
Established Date |
19.04.2004 |
SIC Code |
-- |
|
Telephone# |
91-11-47511000 (30 lines) |
Business Style 1 |
Manufacturer |
|
Fax # |
91-11-27023256 |
Business Style 2 |
Exporter |
|
Homepage |
Product Name 1 |
pharmaceutical products |
|
|
# of employees |
5500
(Approximately) |
Product Name 2 |
-- |
|
Paid up capital |
Rs. 11,750,000/- |
Product Name 3 |
-- |
|
Shareholders |
Directors or
relatives of Directors 100.00% |
Banking |
Standard Chartered Bank |
|
Public Limited Corp. |
NO |
Business Period |
9 Years |
|
IPO |
NO |
International Ins. |
- |
|
Public |
NO |
Rating |
A (61) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
CEO |
|
Associates/Subsidiaries |
-- |
Akumentis Healthcare Limited |
-- |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2012 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
2,371,893,000 |
Current Liabilities |
1,075,357,000 |
|
Inventories |
1,203,253,000 |
Long-term Liabilities |
1,312,306,000 |
|
Fixed Assets |
2,425,678,000 |
Other Liabilities |
250,839,000 |
|
Deferred Assets |
0,000 |
Total Liabilities |
2,638,502,000 |
|
Invest& other Assets |
118,502,000 |
Retained Earnings |
3,469,074,000 |
|
|
|
Net Worth |
3,480,824,000 |
|
Total Assets |
6,119,326,000 |
Total Liab. & Equity |
6,119,326,000 |
|
Total Assets (Previous Year) |
5,240,229,000 |
|
|
|
P/L Statement as of |
31.03.2012 |
(Unit: Indian Rs.) |
|
|
Sales |
6,496,314,000 |
Net Profit |
687,386,000 |
|
Sales(Previous yr) |
5,689,809,000 |
Net Profit(Prev.yr) |
615,703,000 |
|
Report Date : |
09.08.2013 |
IDENTIFICATION DETAILS
|
Name : |
AKUMS DRUGS AND PHARMACEUTICALS LIMITED |
|
|
|
|
Registered Office
: |
304, Mohan Place, LSC, Saraswati Vihar, New Delhi-110 034 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
19.04.2004 |
|
|
|
|
Com. Reg. No.: |
55-125888 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs. 11.750 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239DL2004PLC125888 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
DELA13882B |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAECA7090B |
|
|
|
|
Legal Form : |
A Closely held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer and Exporter of pharmaceutical products and services |
|
|
|
|
No. of Employees
: |
5500 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
A (61) |
|
|||
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
||||
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|||
|
Maximum Credit Limit : |
USD 14000000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established and a reputed company having a fine
track record. It has achieved better growth in its sales turnover and profits
during 2012. Financial position of the company appears to be sound. Trade
relations are reported as trustworthy. Business is active. Payments are
reported to be regular and as per commitments. The company can be considered good for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
We are living in a world
where volatility and uncertainty have become the New Normal. We saw a
change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once
powerful countries in Europe are now fighting for bankruptcy. We have
taken growth in the developing part of the world for granted but economic
growth in China and India has begun to slow. Companies that were synonymous
with their product categories just a few years ago are now no longer in
existence. Kodak, the inventor of the digital camera had to wind up its
operations, HMV, the British entertainment retailing company and Borders, once
the second largest bookstore have shut down due to their inability to evolve
their business models with the changing time. Readers’ Digest, Thomson Register
are no more !
There is another
megatrend happening. The World order is changing as economic power shifts from
West to East. According to McKinsey study, it took Britain more than 100 years
to double its economic output per person during its industrial revolution and the
US later took more than 50 years to do the same. More than a century later,
China and India have doubled their GDP per capital in 12 and 18 years
respectively. By 2020, emerging Asia will become the world’s largest consuming
block, overtaking North America.
The years after the
outbreak of the global financial crisis, the world economy continues to remain
fragile. The Indian economy demonstrated remarkable resilience in the initial
years of the contagion but finally lost ground last year. GDP growth slowed
down. Currency has been weakening. There is a marked deceleration in
agriculture, industry and services. Dampening sentiment led to a cut-back in
investment as well as private consumption expenditure. Inflation remained
at high levels fuelled by the pressure from the food and fuel sectors. The
large fiscal and current account deficit s continued to cause grave concern. It
is imperative that India regains its growth trajectory of 8-9 % sooner than
later. This is crucially important given the need to create gainful livelihood
opportunities for the millions living in poverty as also the large contingent
of young people joining the job market every year.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
ICRA |
|
Rating |
Term Loans A+ |
|
Rating Explanation |
Adequate degree of safety and low credit
risk. |
|
Date |
April, 2013 |
|
Rating Agency Name |
ICRA |
|
Rating |
Non fund facilities A1 |
|
Rating Explanation |
Very strong degree of safety and lowest
credit risk. |
|
Date |
April, 2013 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION DENIED BY
MANAGEMENT NON CORPORATIVE (91-11-47511000)
LOCATIONS
|
Registered Office / Corporate Office : |
304, |
|
Tel. No.: |
91-11-47511000 (30 lines) |
|
Fax No.: |
91-11-27023256 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Manufacturing Unit I |
19-20-21, Sector-6A, I.I.E., SIDCUL, Ranipur, Haridwar -
249403, Uttarakhand |
|
Tel. No.: |
91-1334-239220 – 224, 325982, 84, 85,86 |
|
Fax No.: |
91-1334-239219 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Manufacturing Unit II |
22, Sector-6A, IIE, SIDCUL, Ranipur, Haridwar - 249403 Uttarakhand, India |
|
Tel. No.: |
91-1334-239220 – 224, 325982, 84 ,85, 86 |
|
Fax No.: |
91-1334-239219 |
|
E-Mail : |
|
|
|
|
|
Manufacturing Unit III |
2,3,4,5 Sector-6B, IIE, SIDCUL, Ranipur, Haridwar - 249403
|
|
Tel. No.: |
91-1334- 237100 – 104 |
|
Fax No.: |
91-1334-237105 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Manufacturing Unit IV : |
47, Sector 6B, SIDCUL, Ranipur, Haridwar - 249403 |
|
|
|
|
Manufacturing Unit V : |
48, Sector 6B, SIDCUL, Ranipur, Haridwar - 249403 |
|
|
|
|
Manufacturing Unit VI : |
13, Sector – 6A, SIDCUL, Intergrated Industrial Estate
Ranipur, Haridwar – 249403, |
DIRECTORS
As on: 29.09.2012
|
Name : |
Mr. Sanjeev Jain |
|
Designation : |
Whole-time Director |
|
Address : |
E – 1052, Saraswati Vihar, Dehli – 110 034, |
|
Date of Birth/Age : |
11.04.1966 |
|
Qualification : |
MBBS (BIO) MBA |
|
Date of Appointment : |
19.04.2004 |
|
Voter ID No.: |
DL/03/018/273610 |
|
DIN No.: |
00323433 |
|
|
|
|
Name : |
Mr. Sandeep Jain |
|
Designation : |
Whole-time Director |
|
Address : |
E – 1052, Saraswati Vihar, Dehli – 110 034, |
|
Date of Birth/Age : |
05.08.1967 |
|
Qualification : |
BCom MBA FMSPI AMIMA |
|
Date of Appointment : |
19.04.2004 |
|
Voter ID No.: |
DL/03/018/273693 |
|
DIN No.: |
00323476 |
|
|
|
|
Name : |
Mr. Narendra Dev Sachdeva |
|
Designation : |
While-time Director |
|
Address : |
40/22, 3rd Floor, |
|
Date of Birth/Age : |
15.10.1950 |
|
Qualification : |
B Pharma (Hons) |
|
Date of Appointment : |
27.08.2004 |
|
DIN No.: |
00330005 |
|
|
|
|
Name : |
Mr. Mata Pher Singh |
|
Designation : |
Whole-time Director |
|
Address : |
Plot No. 19,20,21, Sector – 6A, IIE, SIDCUL, Haridwar – 249 403, |
|
Date of Birth/Age : |
28.06.1957 |
|
Qualification : |
BA LLB |
|
Date of Appointment : |
23.05.2004 |
|
DIN No.: |
00356220 |
|
|
|
|
Name : |
Mr. Nandlal Karla |
|
Designation : |
Additional Director |
|
Address : |
4 B A 11, Jawahar Nagar, Jaipur – 302 004, |
|
Date of Birth/Age : |
05.02.1950 |
|
Date of Appointment : |
01.06.2012 |
|
DIN No.: |
05268554 |
KEY EXECUTIVES
|
Name : |
Mrs.Prerna Suneja |
|
Designation : |
Secretary |
|
Address : |
R Block, 75 G |
|
Date of Birth/Age : |
20.10.1984 |
|
Date of Appointment : |
02.03.2010 |
|
PAN No. |
BRHPS2940A |
|
Email ID : |
prernacs@gmail.com |
MAJOR SHAREHOLDERS
As on: 29.09.2012
|
Names of Shareholders |
No. of Shares |
|
Sanjeev Jain |
478275 |
|
Sanjeev Jain and Sons HUF |
22000 |
|
Sanjeev Jain Joint with D C Jain and Sons
HUF |
85000 |
|
Lata Jain |
75 |
|
Sanjeev Jain Joint with Arushi Jain |
300 |
|
Lata Jain Joint with Umang Jain |
50 |
|
Sanjeev Jain Joint with Kiran Jain |
1800 |
|
Sandeep Jain |
447425 |
|
Sandeep Jain and Sons HUF |
52925 |
|
Sandeep Jain Joint with D.C Jain and Sons HUF |
85000 |
|
Sandeep Jain Joint with Kanishk Jain |
300 |
|
Manan Jain U/G Sandeep Jain |
50 |
|
Sandeep Jain Joint with Kiran Jain |
1800 |
|
Total |
1175000 |
Equity Share Break up (Percentage of Total Equity)
As on 29.09.2012
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Exporter of pharmaceutical products and services |
||||
|
|
|
||||
|
Products : |
|
GENERAL INFORMATION
|
Customers : |
· ABBOTT India Limited · Cipla Limited · Alkem Laboratories Limited · Zydus Cadila Healthcare Limited · Alembic Limited · FDC Limited · INTAS Pharmaceuticals Limited · Lupin Limited · Mankind Pharma Private Limited · Wockhardt Limited · Sun Pharmaceuticals Industries Limited |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||
|
No. of Employees : |
5500 (Approximately) |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||
|
Bankers : |
Credit Risk Control, Narain Manzil,
Commercial Branch, M-47, Connaught Circus,
|
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||
|
Facilities : |
NOTE: a)
Cash credit from State Bank of India and Standard
Chartered Bank. |
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Anil Jain D.D and Company Chartered Accountant |
|
Address : |
611, |
|
PAN No.: |
AAIPJ1313K |
|
|
|
|
Associates/Subsidiaries : |
CIN No.: U72900DL2010PLC206414
CIN No.: U99999DL1998PLC095297
CIN No.: U24230DL2006PLC147642
CIN No.: U24232DL2009PLC186841
CIN No.: U24232DL2008PLC185686
CIN No.: U74899DL1994PLC057323
|
CAPITAL STRUCTURE
As on 29.09.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1200000 |
Equity shares |
Rs.10/- each |
Rs. 12.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1175000 |
Equity shares |
Rs.10/- each |
Rs. 11.750 Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
|
31.03.2012 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
|
|
11.750 |
|
(b) Reserves & Surplus |
|
|
3469.074 |
|
(c) Money
received against share warrants |
|
|
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
|
|
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
|
|
3480.824 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
|
|
115.943 |
|
(b) Deferred tax liabilities (Net) |
|
|
213.790 |
|
(c) Other long term
liabilities |
|
|
15.060 |
|
(d) long-term
provisions |
|
|
10.394 |
|
Total Non-current
Liabilities (3) |
|
|
355.187 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
|
|
1196.363 |
|
(b) Trade
payables |
|
|
798.882 |
|
(c) Other
current liabilities |
|
|
261.415 |
|
(d) Short-term
provisions |
|
|
26.655 |
|
Total Current
Liabilities (4) |
|
|
2283.315 |
|
|
|
|
|
|
TOTAL |
|
|
6119.326 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
|
|
2397.658 |
|
(ii)
Intangible Assets |
|
|
28.020 |
|
(iii)
Capital work-in-progress |
|
|
112.352 |
|
(iv)
Intangible assets under development |
|
|
0.000 |
|
(b) Non-current Investments |
|
|
6.150 |
|
(c) Deferred tax assets (net) |
|
|
0.000 |
|
(d) Long-term Loan and Advances |
|
|
458.808 |
|
(e) Other
Non-current assets |
|
|
0.000 |
|
Total Non-Current
Assets |
|
|
3002.988 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
|
|
0.000 |
|
(b)
Inventories |
|
|
1203.253 |
|
(c) Trade
receivables |
|
|
1217.327 |
|
(d) Cash
and cash equivalents |
|
|
4.641 |
|
(e)
Short-term loans and advances |
|
|
643.986 |
|
(f) Other
current assets |
|
|
47.131 |
|
Total
Current Assets |
|
|
3116.338 |
|
|
|
|
|
|
TOTAL |
|
|
6119.326 |
|
SOURCES OF FUNDS |
|
31.03.2011 |
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
11.750 |
11.750 |
|
|
2] Share Application Money |
|
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
|
2781.242 |
2165.538 |
|
|
4] (Accumulated Losses) |
|
0.000 |
0.000 |
|
|
NETWORTH |
|
2792.992 |
2177.288 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
1473.486 |
912.451 |
|
|
2] Unsecured Loans |
|
0.000 |
0.000 |
|
|
TOTAL BORROWING |
|
1473.486 |
912.451 |
|
|
DEFERRED TAX LIABILITIES |
|
171.276 |
123.166 |
|
|
|
|
|
|
|
|
TOTAL |
|
4437.754 |
3212.905 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
2180.096 |
1778.659 |
|
|
Capital work-in-progress |
|
61.909 |
3.668 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
6.150 |
5.650 |
|
|
DEFERREX TAX ASSETS |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
1058.686
|
740.856
|
|
|
Sundry Debtors |
|
1054.084
|
971.172
|
|
|
Cash & Bank Balances |
|
62.142
|
55.848
|
|
|
Other Current Assets |
|
0.000
|
0.000
|
|
|
Loans & Advances |
|
817.162
|
372.131
|
|
Total
Current Assets |
|
2992.074
|
2140.007
|
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
457.152
|
540.839
|
|
|
Other Current Liabilities |
|
176.905
|
76.636
|
|
|
Provisions |
|
168.418
|
97.604
|
|
Total
Current Liabilities |
|
802.475
|
715.079
|
|
|
Net Current Assets |
|
2189.599
|
1424.928
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
4437.754 |
3212.905 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
6496.314 |
5689.809 |
4109.312 |
|
|
|
Other Income |
121.429 |
78.119 |
80.906 |
|
|
|
TOTAL |
6617.743 |
5767.928 |
4190.218 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Consumption materials changes inventories |
-- |
4015.669 |
2987.377 |
|
|
|
Cost raw material consumed |
4366.087 |
-- |
-- |
|
|
|
Changes in inventories of finished goods, work-in-progress and
stock-in-trade |
68.053 |
-- |
-- |
|
|
|
Manufacturing service costs |
-- |
181.937 |
133.719 |
|
|
|
Employee related expenses |
651.073 |
489.307 |
317.391 |
|
|
|
Administrative selling other expenses |
-- |
110.915 |
79.196 |
|
|
|
Other expenses |
433.989 |
-- |
-- |
|
|
|
TOTAL |
5519.202 |
4797.828 |
3517.683 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
1098.541 |
970.100 |
672.535 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
122.242 |
91.666 |
65.328 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
976.299 |
878.434 |
607.207 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
109.837 |
89.339 |
72.808 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
866.462 |
789.095 |
534.396 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
179.076 |
173.392 |
131.420 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
687.386 |
615.703 |
402.976 |
|
|
|
|
|
|
|
|
|
Add |
BALANCE
CARRIED TO THE B/S |
687.386 |
615.703 |
402.976 |
|
|
|
|
|
|
|
|
|
|
TOTAL EARNINGS
IN FOREIGN CURRENCY |
24.305 |
NA |
28.900 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
585.00 |
524.00 |
342.96 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
PAT / Total Income |
(%) |
10.39
|
10.67
|
9.62
|
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
13.34
|
13.87
|
13.00
|
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
15.63
|
15.26
|
13.64
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.25
|
0.28
|
0.25
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.38
|
0.81
|
0.74
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.36
|
3.73
|
2.99
|
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
---------------------- |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
--------------------- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
Yes |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
---------------------- |
|
22] |
Litigations that the firm
/ promoter involved in |
---------------------- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
---------------------- |
|
26] |
Buyer visit details |
No |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director,
if available |
No |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
Yes |
|
34] |
External Agency Rating,
if available |
Yes |
INDEX CHARGES:
|
S.No. |
Charge ID |
Date of Charge
Creation/Modification |
Charge amount
secured |
Charge Holder |
Address |
Service Request
Number (SRN) |
|
1 |
10217825 |
21/12/2010 * |
150,000,000.00 |
STANDARD CHARTERED BANK |
CREDIT RISK CONTROL, NARAIN MANZIL, 23 BARAKHAMBA |
B01972181 |
|
2 |
10217291 |
21/12/2010 * |
250,000,000.00 |
STANDARD CHARTERED BANK (acting as an
Security Agent) |
CREDIT RISK CONTROL, NARAIN MANZIL, 23 BARAKHAMBA |
B01972157 |
|
3 |
10120161 |
21/08/2008 |
200,000,000.00 |
ICICI BANK LIMITED |
LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, Gujarat - 390015, INDIA |
A44659969 |
|
4 |
10019466 |
30/01/2012 * |
1,500,000,000.00 |
State Bank of India |
Commercial Branch, M-47, Connaught Circus, New Delhi, Delhi - 110001,
INDIA |
B32485583 |
* Date of charge modification
PHARMA
INDUSTRY STRUCTURE AND DEVELOPMENTS:
The Pharmaceuticals industry
in
The Indian pharmaceutical industry is the world’s second largest by
volume and is likely to lead the manufacturing sector of
OVERVIEW:
Subject was established and formed in the year 2004. Initially, Company
started the production with one manufacturing plant only. In eight years, the
company has growth and achieved greater heights with successfully running 6
plants in Haridwar, in addition to newly setting if centralized warehousing and
centralized R and D unit formulation development. The company was fully
equipped plants have made it, a largest pharmaceutical formulations
manufacturer in
FIXED ASSETS:
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 61.11 |
|
|
1 |
Rs. 94.77 |
|
Euro |
1 |
Rs. 81.54 |
INFORMATION DETAILS
|
Information
Gathered by : |
PLV |
|
|
|
|
Report Prepared
by : |
ANK |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
4 |
|
PAID-UP CAPITAL |
1~10 |
4 |
|
OPERATING SCALE |
1~10 |
8 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
--PROFITABILIRY |
1~10 |
7 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
8 |
|
--CREDIT LINES |
1~10 |
8 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
61 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NB |
NEW BUSINESS |
||
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.